Cart
sales@molnova.com
5,6,7,3,4,5-Hexamethoxyflavanone
CAS No. 74064-17-8
5,6,7,3,4,5-Hexamethoxyflavanone( —— )
Catalog No. M32322 CAS No. 74064-17-8
5,6,7,3',4',5'-hexamethoxyflavone has antiproliferative activity against four human cancer cell lines (Aspc-1, HCT-116, HepG-2 and SUN-5).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 551 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5,6,7,3,4,5-Hexamethoxyflavanone
-
NoteResearch use only, not for human use.
-
Brief Description5,6,7,3',4',5'-hexamethoxyflavone has antiproliferative activity against four human cancer cell lines (Aspc-1, HCT-116, HepG-2 and SUN-5).
-
Description5,6,7,3',4',5'-hexamethoxyflavone has antiproliferative activity against four human cancer cell lines (Aspc-1, HCT-116, HepG-2 and SUN-5).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number74064-17-8
-
Formula Weight404.4
-
Molecular FormulaC21H24O8
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nat Prod Res . 2021 Aug 5;1-6.
molnova catalog
related products
-
Methyl jasmonate
Methyl jasmonate is a phytohormone involved in plant defenses under stress conditions. Methyl jasmonate can improve antioxidant properties of blueberry leaf extracts (mainly anthocyanins), and decrease the viability and migration capacity of AGS cells. Anticarcinogenic activity.
-
ML092
Cruzain-IN-1 is a covalent and reversible Cruzain inhibitor (IC50: 10 nM).
-
Magrolimab
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
